Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas.

doi:10.3390/ijms222111564

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas.

International journal of molecular sciences - 26 Oct 2021

De Vita Alessandro, Vanni Silvia, Fausti Valentina, Cocchi Claudia, Recine Federica, Miserocchi Giacomo, Liverani Chiara, Spadazzi Chiara, Bassi Massimo, Gessaroli Manlio, Campobassi Angelo, De Luca Giovanni, Pieri Federica, Farnedi Anna, Franchini Eugenia, Ferrari Anna, Domizio Chiara, Cavagna Enrico, Gurrieri Lorena, Bongiovanni Alberto, Riva Nada, Calpona Sebastiano, Di Menna Giandomenico, Debonis Silvia Angela, Ibrahim Toni, Mercatali Laura

Abstract excerpt

Adult rhabdomyosarcoma (RMS) represents an uncommon entity with an incidence of less than 3% of all soft tissue sarcomas (STS). Consequently, the natural history and the clinical management of this disease are infrequently reported. In order to fill this gap, we investigated the molecular biology of an adult RMS case series. The expression of epithelial mesenchymal transition-related gene and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial-Mesenchymal Transition

Share to Genomics

Share to Microsatellite Instability

Share to Rhabdomyosarcoma

Share to Sarcoma

Share to Soft Tissue Neoplasms

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 34768995
DOI: 10.3390/ijms222111564
PMCID: PMC8584142

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas.PMID 34768995Read ↗

Molecular profile of head and neck rhabdomyosarcomas: A systematic review and meta-analysis.Semantic proximity Read ↗

Rhabdomyosarcoma: How Advanced Molecular Methods Are Shaping the Diagnostic and Therapeutic Paradigm.Semantic proximity Read ↗

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-StudiengruppeSemantic proximity Read ↗

Genetics, epigenetics and redox homeostasis in rhabdomyosarcoma: Emerging targets and therapeuticsSemantic proximity Read ↗

Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypesSemantic proximity Read ↗

Rhabdomyosarcoma: Updates on classification and the necessity of molecular testing beyond immunohistochemistry.Semantic proximity Read ↗

Transcriptomic profiling of recurrent Rhabdomyosarcoma: Pre- and post-treatment tissue analysis reveals molecular characteristics of acquired resistance.Semantic proximity Read ↗

The current landscape of rhabdomyosarcomas: an update.Semantic proximity Read ↗

Molecular diagnostics in the management of rhabdomyosarcomaSemantic proximity Read ↗

Childhood RhabdomyosarcomaSemantic proximity Read ↗

Aberrant CDK4 Amplification in Refractory Rhabdomyosarcoma as Identified by Genomic ProfilingSemantic proximity Read ↗

Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.